Roivant Sciences Ltd. — Director's Dealing 2026

Feb 13, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2026-02-11

Reporting Person: QVT Financial LP (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-11	Common Shares	S	425000	$26.67	Disposed	15928113	Indirect
2026-02-12	Common Shares	S	150000	$26.72	Disposed	15778113	Indirect
2026-02-12	Common Shares	S	275000	$26.76	Disposed	15503113	Indirect
2026-02-13	Common Shares	S	150784	$26.49	Disposed	15352329	Indirect
2026-02-13	Common Shares	S	225000	$26.50	Disposed	15127329	Indirect

Footnotes

F1: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 25,161,237 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.